Mazdutide
£140.00
If you are looking for a Certificate Of Analysis, please email research@peptidesuk.co.uk to have it sent to you.
Please Note: Many sites are displaying counterfeit COAs, so ours is provided upon request.
You may also like…
Product Description
Mazdutide (also known as IBI362) is an investigational synthetic peptide designed as a dual GLP-1 and glucagon receptor agonist, studied for its anti-obesity and metabolic regulation properties. It mimics the natural incretin hormones to reduce appetite while enhancing energy expenditure and fat metabolism, making it a promising candidate for obesity, diabetes, and liver disease models.
Benefits (Based on Preclinical and Clinical Research):
-
Promotes body fat reduction and weight loss
-
Enhances energy expenditure via glucagon receptor activation
-
Suppresses appetite and improves satiety through GLP-1 activity
-
Improves insulin sensitivity and glucose homeostasis
-
Investigated in non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome
Who Uses This:
Researchers studying obesity, type 2 diabetes, lipid metabolism, and hepatic fat regulation use Mazdutide in advanced metabolic and endocrinological research models.
Why Choose Mazdutide:
-
Dual agonist for GLP-1 and glucagon with extended activity
-
Supplied in sterile, lyophilized format for lab precision
-
Includes Certificate of Analysis (COA) and verified purity
-
Effective in preclinical models of metabolic dysregulation
Documentation and Quality:
Each vial is delivered with a COA, sealed in tamper-proof lab-grade packaging, and shipped under validated cold-chain protocols. Third-party tested for identity, purity, and stability.
Disclaimer:
Mazdutide is for research use only. Not intended for human use, therapeutic application, or consumption. To be used exclusively by licensed research institutions and professionals.
